Contact
Please use this form to send email to PR contact of this press release:
Regulatory update – GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
TO:
Please use this form to send email to PR contact of this press release:
Regulatory update – GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
TO: